Treace
Ponte Vedra, Florida, United States · Biotechnology, Healthcare, Health Care
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual s
Key facts
- Headquarters
- Ponte Vedra, Florida, United States
- Employees
- Unknown
- Industries
- Biotechnology, Healthcare, Health Care
- Status
- Public (TMCI)
- Website
- http://treace.com
- Company page
Recent activity at Treace
- : SEC 8-K (1.01): On December 17, 2025, Treace Medical Concepts, Inc. entered into two significant Loan Agreements: a Term Loan Agreement with SLR Investment Corp. allowing up to $125 million in borrowing capacity, drawing $60 million upon closing, and a Revolving Loan Agreement with Gemino Healthcare Finance, LLC providing an additional $30 million. The Term Loan includes revenue-based contingencies for further borrowing of up to $65 million. These agreements are crucial for supporting the company's operational and strategic growth initiatives.
- : Treace Medical Concepts, Inc. Launches IntelliGuide™ PSI for Personalized Surgical Treatment of Midfoot Deformities.
- : Guy Guglielmino Joins Treace Medical Concepts, Inc. as Chief Commercial Officer
- : Treace Medical Completes Acquisition Of Technology Enabling Patient Specific Instrumentation And Reports On Clinical Cases Using Psi With The Lapiplasty® System
- : Treace Medical Concepts To Acquire Technology Enabling Patient Specific Instrumentation For Foot And Ankle Surgeries
- : Treace Secures Up To $150 Million In Debt Financing
- : TREACE MEDICAL CONCEPTS, INC.
- : TREACE MEDICAL CONCEPTS, INC.
Treace funding history
| Date | Round | Amount |
|---|---|---|
| May 2022 | Debt Financing | $150.0M |
| May 2017 | Venture | $5.9M |
| Feb 2017 | Venture | $2.1M |
Leadership
- RICHARD MOTT, Director
- JOHN TREACE, Director
- F BAYS, Director
- JAMES TREACE, Director
- THOMAS TIMBIE, Director
- JOHN TREACE, Executive Officer, Director
- RICHARD MOTT, Director
- JOHN TREACE, Director
- F BAYS, Director
- JAMES TREACE, Director
- THOMAS TIMBIE, Director
- JOHN TREACE, Executive Officer, Director
Verified email and direct lines for Treace’s decision-makers are on Fundz. See plans
Employee benefit plans
Treace files 5 employee benefit plans with the U.S. Department of Labor, including a retirement plan. The next plan year renews in Dec 2026.
Treace in the news
- TRACE - NASA Science (.gov) (Dec 31, 2025)
- Traffic transparency: unleashing the power of Cloudflare Trace - Cloudflare Blog (Sep 25, 2023)
- You shed DNA everywhere you go – trace samples in the water, sand and air are enough to identify who you are, raising ethical questions about privacy - The Conversation (May 15, 2023)
- ExoMars Trace Gas Orbiter (TGO) - Robotic Exploration - Science Portal - ESA Science & Technology (Mar 12, 2020)
- Snow Measurement Guidelines - National Weather Service (.gov) (Mar 13, 2016)
- What Is TRACE? Insight into Trade Reporting and Compliance - Investopedia (Mar 25, 2017)
- Vivid Rainbow Roads Trace Illuminated Pathways Across Forests and Beaches - thisiscolossal.com (Jun 06, 2018)
- The failure of test and trace shows the folly of handing huge contracts to private giants | Richard Brooks - The Guardian (Oct 13, 2020)
Companies similar to Treace
- Dror Ortho-Design · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- RIVANNA · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Monteris Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- SynerFuse, Inc. · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
- Tenon Medical · Biotechnology, Healthcare, Health Care, Manufacturing, Medical, Medical Device
About Treace: questions and answers
What does Treace do?
Treace Medical Concepts, Inc. is a medical technology company with the goal of advancing the standard of care for the surgical management of bunion deformities and related midfoot correction. Bunions are complex 3-dimensional deformities that originate from an unstable joint in the middle of the foot and affect approximately 65 million Americans1, of which Treace estimates 1.1 million are annual s
Where is Treace headquartered?
Treace is headquartered in Ponte Vedra, Florida, United States.
Has Treace raised funding?
Yes. Fundz has recorded 3 funding events for Treace. The most recent, Debt Financing of $150.0M, was in May 2022.
What is the latest news on Treace?
On Dec 16, 2025, SEC 8-K (1.01): On December 17, 2025, Treace Medical Concepts, Inc. entered into two significant Loan Agreements: a Term Loan Agreement with SLR Investment Corp. allowing up to $125 million in borrowing capacity, drawing $60 million upon closing, and a Revolving Loan Agreement with Gemino Healthcare
Is Treace a public company?
Yes. Treace is publicly traded under the ticker TMCI.
Source: Fundz records from SEC filings, press releases and company announcements. How Fundz measures data accuracy